CYTOKINETICS, INCORPORATED: 10-Q filed 2022-08-05
What CYTOKINETICS, INCORPORATED reported in its quarterly report filed 2022-08-05 (fiscal Q2 2022): 39 published measures, 110 facts as tagged in accession 0000950170-22-015117.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2022-08-05
- Fiscal period
- fiscal Q2 2022
- Accession
- 0000950170-22-015117 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CYTOKINETICS, INCORPORATED filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 771,717,000 | USD | |
| At 2021-12-31 | 841,319,000 | USD |
Total liabilities
Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 660,303,000 | USD | |
| At 2021-12-31 | 597,456,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 111,414,000 | USD | |
| At 2022-03-31 | 116,261,000 | USD | |
| At 2021-12-31 | 243,863,000 | USD | |
| At 2021-06-30 | 16,489,000 | USD | |
| At 2021-03-31 | 67,846,000 | USD | |
| At 2020-12-31 | 113,383,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 93,631,000 | USD | |
| At 2021-12-31 | 112,666,000 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -19,820,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -109,265,000 | USD | 181 |
| 2022-01-01 to 2022-03-31 | -89,445,000 | USD | 90 |
| 2021-04-01 to 2021-06-30 | -61,554,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -108,658,000 | USD | 181 |
| 2021-01-01 to 2021-03-31 | -47,104,000 | USD | 90 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | -117,286,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | -59,015,000 | USD | 181 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 1,799,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 15,418,000 | USD | 181 |
Contract revenue excluding tax
Revenue from customer contracts excluding assessed taxes under this specific taxonomy concept. It is not automatically comparable to older revenue tags.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 88,968,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 90,116,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 2,843,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 9,391,000 | USD | 181 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 97,262,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | -421,000 | USD | 181 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 989,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 13,605,000 | USD | 181 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | -1,306,304,000 | USD | |
| At 2022-01-01 | -1,197,039,000 | USD | |
| At 2021-12-31 | -1,207,620,000 | USD |
Basic weighted-average shares
Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 85,731 | shares | 91 |
| 2022-01-01 to 2022-06-30 | 85,366 | shares | 181 |
| 2021-04-01 to 2021-06-30 | 71,754 | shares | 91 |
| 2021-01-01 to 2021-06-30 | 71,476 | shares | 181 |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 85,731 | shares | 91 |
| 2022-01-01 to 2022-06-30 | 85,366 | shares | 181 |
| 2021-04-01 to 2021-06-30 | 71,754 | shares | 91 |
| 2021-01-01 to 2021-06-30 | 71,476 | shares | 181 |
Basic earnings per share
Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -0.23 | USD/shares | 91 |
| 2022-01-01 to 2022-06-30 | -1.28 | USD/shares | 181 |
| 2021-04-01 to 2021-06-30 | -0.86 | USD/shares | 91 |
| 2021-01-01 to 2021-06-30 | -1.52 | USD/shares | 181 |
Diluted earnings per share
Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -0.23 | USD/shares | 91 |
| 2022-01-01 to 2022-06-30 | -1.28 | USD/shares | 181 |
| 2021-04-01 to 2021-06-30 | -0.86 | USD/shares | 91 |
| 2021-01-01 to 2021-06-30 | -1.52 | USD/shares | 181 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 78,586,000 | USD | |
| At 2021-12-31 | 73,271,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 21,180,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 12,354,000 | USD | 181 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -10,874,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -88,731,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -54,797,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -95,408,000 | USD | 181 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 602,250,000 | USD | |
| At 2021-12-31 | 535,672,000 | USD |
Interest expense
Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 2,807,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 5,553,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 4,073,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 8,061,000 | USD | 181 |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 66,843,000 | USD | |
| At 2021-12-31 | 71,860,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 14,078,000 | USD | |
| At 2021-12-31 | 21,087,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 1,973,000 | USD | |
| At 2021-12-31 | 51,819,000 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 99,842,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 178,847,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 57,640,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 104,799,000 | USD | 181 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 57,126,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 103,061,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 36,443,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 68,004,000 | USD | 181 |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-01-01 | 1,402,792,000 | USD | |
| At 2021-12-31 | 1,452,268,000 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | -4,494,000 | USD | |
| At 2021-12-31 | -869,000 | USD |
Operating lease right-of-use asset
Carrying amount of the right to use leased assets under operating leases. It reflects discounted remaining payments, not the value of the underlying property.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 72,161,000 | USD | |
| At 2021-12-31 | 73,138,000 | USD |
Operating lease liability
Present value of remaining operating lease payments. Discount-rate choices and lease terms affect the amount; it is not the sum of undiscounted future rent.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 127,035,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 1,444,000 | USD | |
| At 2021-12-31 | 4,457,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 36,702,000 | USD | |
| At 2021-12-31 | 34,370,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2022-06-30 | 14,251,000 | USD | |
| At 2021-12-31 | 12,215,000 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | -109,265,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | -108,658,000 | USD | 181 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | -20,725,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | -112,890,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | -61,626,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | -108,829,000 | USD | 181 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 42,716,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 75,786,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 21,197,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 36,795,000 | USD | 181 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 2,748,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 1,080,000 | USD | 181 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-04-01 to 2022-06-30 | 864,000 | USD | 91 |
| 2022-01-01 to 2022-06-30 | 1,279,000 | USD | 181 |
| 2021-04-01 to 2021-06-30 | 187,000 | USD | 91 |
| 2021-01-01 to 2021-06-30 | 477,000 | USD | 181 |
Interest paid, net
Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | 5,474,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | 4,591,000 | USD | 181 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2022-01-01 to 2022-06-30 | -54,846,000 | USD | 181 |
| 2021-01-01 to 2021-06-30 | -1,719,000 | USD | 181 |
Inspect the source
- Entity
- CYTOKINETICS, INCORPORATED / CIK 0001061983
- Captured
- 2026-09-20T05:18:32.562Z
- SEC response SHA-256
3f285d099e85e8f676aa27a587c2a7f62b31ddcaa4f296c2bd5345f75199413c
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001061983.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))